Tissue Array
Log In | My Account | Cart (0 items) - $0.00
US Biomax, Inc.
 

MC2082

Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, 208 cases/208 cores
Unstained: $455.00 Add to Cart
H&E (MC2082s*): $455.00 Add to Cart

Microarray Panel:Multiple organ tumor microarray, containing 8 cases adenocarcinoma of stomach, 4 each of esophagus adenocarcinoma and squamous cell carcinoma, 8 adenocarcinoma of colon, 8 hepatocellular carcinoma of liver, 8 adenocarcinoma of pancreas, 4 each of lung squamous cell carcinoma, adenocarcinoma, large cell carcinoma and small cell carcinoma, 4 each of brain astrocytoma and gliobastoma, 8 lymphoma of spleen, 4 each of thyroid papillary carcinoma and follicular carcinoma, 4 each of lymph node Hodgkin lymphoma and non-Hodgkin lymphoma, 8 squamous cell carcinoma of pate, 8 squamous cell carcinoma of skin, 4 each of fibrosarcoma and liposarcoma, 8 malignant melanoma, 8 each of breast infiltrating ductal carcinoma and invasive lobular carcinoma, 8 adenocarcinoma from ovary epithelium, 4 tumor each from germ cell and stroma, 8 adenocarcinoma of endometrium, 8 adenocarcinoma of prostate, 8 seminoma of testis, 8 each of kidney clear cell carcinoma and granular cell carcinoma, 8 transitional cell carcinoma of bladder, single core per case
Cores:208
Cases:208
Layout:16 cols × 13 rows
Core Diameter:1 mm
Thickness:5 µm
Quality Control:Anti-Actin confirmed
Applications:Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.
Notes:Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.

*Tissue Microarray Slide Types:

  • Unstained: unstained paraffin tissue microarray slide.
  • Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
  • H & E: Hematoxylin and Eosin stained tissue microarray slide.

Microarray Panel Display

 
Slide Label: US Biomax, Inc. Tissue Array
12345678910111213141516
A Sto Sto Sto Sto Sto Sto Sto Sto Eso Eso Eso Eso Eso Eso Eso Eso
B Col Col Col Col Col Col Col Col Liv Liv Liv Liv Liv Liv Liv Liv
C Pan Pan Pan Pan Liv Pan Pan Pan Lun Lun Lun Lun Lun Lun Lun Lun
D Lun Lun Lun Lun Lun Lun Lun Lun Cer Cer Cer Cer Cer Cer Cer Cer
E Spl Spl Spl Spl Spl Spl Spl Spl Thr Thr Thr Thr Thr Thr Thr Thr
F Lym Lym Lym Lym Lym Lym Lym Lym Che Gin Ski Sof Nos Nos Nos Nos
G Ski Ski Ski Ski Ski Ski Ski Ski Ski Ski Ski Ski Adi Ski Ski Ski
H Ski Ski Ski Ski Ski Ski Rec Rec Bre Bre Bre Bre Bre Bre Bre Bre
I Bre Bre Bre Bre Bre Bre Bre Bre Ova Ova Ova Ova Ova Ova Ova Ova
J Ova Ova Ova Ova Ova Ova Ova Ova Ute Ute Ute Ute Ute Ute Ute Ute
K Ute Ute Ute Ute Ute Ute Ute Ute Pro Pro Pro Pro Pro Pro Pro Pro
L Tes Tes Tes Tes Tes Tes Tes Tes Kid Kid Kid Kid Kid Kid Kid Kid
M Kid Kid Kid Kid Kid Kid Kid Kid Bla Bla Bla Bla Bla Bla Bla Bla
Legend: Adi - Adipose, Bla - Bladder, Bre - Breast, Cer - Cerebrum, Che - Cheek, Col - Colon, Eso - Esophagus, Gin - Gingiva, Kid - Kidney, Liv - Liver, Lun - Lung, Lym - Lymph node, Nos - Nose, Ova - Ovary, Pan - Pancreas, Pro - Prostate, Rec - Rectum, Ski - Skin, Sof - Soft palate, Spl - Spleen, Sto - Stomach, Tes - Testis, Thr - Thyroid, Ute - Uterine cervix

- Benign tumor, - Malignant tumor, - Malignant tumor (stage I), - Malignant tumor (stage II), - Malignant tumor (stage III), - Malignant tumor (stage IIIa), - Malignant tumor (stage IIIb), - Malignant tumor (stage IIa), - Malignant tumor (stage IIb), - Malignant tumor (stage IV), - Malignant tumor (stage Ia), - Malignant tumor (stage Ib), - Malignant tumor (stage Ic)

Specification Sheet

Pos No. Sex Age Organ Pathology diagnosis Grade Stage TNM Type †
A1 1 M 59 Stomach Adenocarcinoma 1 II T3N0M0 Malignant
A2 2 M 56 Stomach Adenocarcinoma 2 Ib T2N0M0 Malignant
A3 3 M 60 Stomach Adenocarcinoma 2 Ib T2N0M0 Malignant
A4 4 M 61 Stomach Adenocarcinoma 1 Ib T2N0M0 Malignant
A5 5 F 66 Stomach Adenocarcinoma (sparse) 3 II T3N0M0 Malignant
A6 6 M 60 Stomach Adenocarcinoma 3 Ib T2N0M0 Malignant
A7 7 M 65 Stomach Adenocarcinoma 3 IIIa T4N0M0 Malignant
A8 8 M 40 Stomach Adenocarcinoma 3 IIIa T4N0M0 Malignant
A9 9 M 71 Esophagus Adenocarcinoma 1 III T4N0M0 Malignant
A10 10 M 70 Esophagus Adenocarcinoma 2 IIa T2N0M0 Malignant
A11 11 M 63 Esophagus Adenocarcinoma 3 IIa T3N0M0 Malignant
A12 12 M 53 Esophagus Adenocarcinoma 3 IIa T3N0M0 Malignant
A13 13 M 58 Esophagus Squamous cell carcinoma 1 IIa T2N0M0 Malignant
A14 14 M 52 Esophagus Squamous cell carcinoma 2 IIa T3N0M0 Malignant
A15 15 M 46 Esophagus Squamous cell carcinoma 2 IIa T3N0M0 Malignant
A16 16 F 65 Esophagus Squamous cell carcinoma 3 IIa T3N0M0 Malignant
B1 17 M 59 Colon Adenocarcinoma 1 II T4N0M0 Malignant
B2 18 M 46 Colon Adenocarcinoma 2 II T4N0M0 Malignant
B3 19 F 58 Colon Adenocarcinoma 2 II T4N0M0 Malignant
B4 20 F 79 Colon Adenocarcinoma 2–3 II T4N0M0 Malignant
B5 21 M 66 Colon Adenocarcinoma 1 II T4N0M0 Malignant
B6 22 M 56 Colon Adenocarcinoma 2 II T2N0M0 Malignant
B7 23 M 53 Colon Adenocarcinoma 2 II T4N0M0 Malignant
B8 24 M 46 Colon Adenocarcinoma 3 II T4N0M0 Malignant
B9 25 M 46 Liver Hepatocellular carcinoma with necrosis 2 II T2N0M0 Malignant
B10 26 M 33 Liver Hepatocellular carcinoma 2 III T3N0M0 Malignant
B11 27 F 67 Liver Hepatocellular carcinoma 1 I T1N0M0 Malignant
B12 28 F 35 Liver Hepatocellular carcinoma 2 III T3N0M0 Malignant
B13 29 M 19 Liver Hepatocellular carcinoma 2 II T2N0M0 Malignant
B14 30 M 47 Liver Hepatocellular carcinoma 3 II T2N0M0 Malignant
B15 31 M 75 Liver Hepatocellular carcinoma 3 II T2N0M0 Malignant
B16 32 M 37 Liver Hepatocellular carcinoma 2 II T2N0M0 Malignant
C1 33 M 50 Pancreas Duct adenocarcinoma 2 III T2N1M0 Malignant
C2 34 F 53 Pancreas Duct adenocarcinoma with necrosis 2 II T3N0M0 Malignant
C3 35 M 55 Pancreas Duct adenocarcinoma 2 II T3N0M0 Malignant
C4 36 M 44 Pancreas Duct adenocarcinoma 2 II T3N0M0 Malignant
C5 37 F 76 Liver Duct adenocarcinoma (hepatic tissue) – III T4N0M0 Malignant
C6 38 M 41 Pancreas Duct adenocarcinoma 2 III T4N1M0 Malignant
C7 39 F 54 Pancreas Duct adenocarcinoma 2 I T2N0M0 Malignant
C8 40 F 57 Pancreas Duct adenocarcinoma 2–3 I T2N0M0 Malignant
C9 41 M 44 Lung Squamous cell carcinoma 2 II T2N1M0 Malignant
C10 42 M 68 Lung Squamous cell carcinoma with necrosis 2 I T2N0M0 Malignant
C11 43 M 56 Lung Squamous cell carcinoma 2 IIIa T3N0M0 Malignant
C12 44 M 69 Lung Squamous cell carcinoma 3 I T1N0M0 Malignant
C13 45 F 42 Lung Adenocarcinoma 2 IIIa T3N1M0 Malignant
C14 46 M 70 Lung Adenocarcinoma 2 I T1N0M0 Malignant
C15 47 M 51 Lung Adenocarcinoma 3 I T2N0M0 Malignant
C16 48 M 49 Lung Adenocarcinoma 3 I T1N0M0 Malignant
D1 49 F 65 Lung Large cell carcinoma – II T2N1M0 Malignant
D2 50 M 62 Lung Large cell carcinoma – III T3N0M0 Malignant
D3 51 M 60 Lung Large cell carcinoma (sparse) – II T2N1M0 Malignant
D4 52 M 60 Lung Large cell carcinoma – I T2N0M0 Malignant
D5 53 M 73 Lung Small cell carcinoma with necrosis – IIIa T3N1M0 Malignant
D6 54 F 66 Lung Small cell carcinoma – II T2N1M0 Malignant
D7 55 M 54 Lung Small cell carcinoma – II T2N1M0 Malignant
D8 56 M 50 Lung Small cell carcinoma – I T2N0M0 Malignant
D9 57 F 36 Cerebrum Astrocytoma (brain tissue) – – – Benign
D10 58 M 35 Cerebrum Astrocytoma 2 – – Benign
D11 59 F 48 Cerebrum Astrocytoma 2 – – Benign
D12 60 F 36 Cerebrum Astrocytoma 2–3 – – Malignant
D13 61 F 31 Cerebrum Glioblastoma 4 – – Malignant
D14 62 F 52 Cerebrum Glioblastoma 4 – – Malignant
D15 63 F 41 Cerebrum Glioblastoma 4 – – Malignant
D16 64 F 6 Cerebrum Glioblastoma 4 – – Malignant
E1 65 F 43 Spleen Diffuse B-cell lymphoma – – – Malignant
E2 66 M 47 Spleen B-cell lymphoma – – – Malignant
E3 67 M 46 Spleen B-cell lymphoma – – – Malignant
E4 68 M 40 Spleen Diffuse B-cell lymphoma – – – Malignant
E5 69 M 21 Spleen Diffuse B-cell lymphoma – – – Malignant
E6 70 F 60 Spleen Diffuse plasmacytoid B-cell lymphoma – – – Malignant
E7 71 M 38 Spleen Diffuse B-cell lymphoma – – – Malignant
E8 72 M 18 Spleen Diffuse B-cell lymphoma – – – Malignant
E9 73 F 36 Thyroid Papillary carcinoma – I T3N0M0 Malignant
E10 74 F 60 Thyroid Papillary carcinoma – II T2N0M0 Malignant
E11 75 F 70 Thyroid Papillary carcinoma – II T2N0M0 Malignant
E12 76 F 65 Thyroid Papillary carcinoma – II T2N0M0 Malignant
E13 77 M 63 Thyroid Follicular carcinoma 3 II T3N0M0 Malignant
E14 78 F 36 Thyroid Follicular carcinoma 2 I T3N0M0 Malignant
E15 79 F 43 Thyroid Follicular carcinoma 2 I T2N0M0 Malignant
E16 80 F 29 Thyroid Follicular carcinoma 3 I T1N0M0 Malignant
F1 81 M 17 Lymph node Mixed Hodgkin lymphoma of right neck – – – Malignant
F2 82 F 73 Lymph node Mixed Hodgkin lymphoma of right neck – – – Malignant
F3 83 F 31 Lymph node Lymphocyte predominant Hodgkin lymphoma on right clavicle – – – Malignant
F4 84 M 32 Lymph node Mixed Hodgkin lymphoma of neck – – – Malignant
F5 85 F 25 Lymph node T-cell lymphoma of right neck – – – Malignant
F6 86 F 68 Lymph node Follicular center cell lymphoma of left groin – – – Malignant
F7 87 M 55 Lymph node T-cell lymphoma of right oxter – – – Malignant
F8 88 F 76 Lymph node Anaplastic large cell lymphoma of left neck – – – Malignant
F9 89 F 50 Cheek Squamous cell carcinoma (sparse) – I T1N0M0 Malignant
F10 90 M 49 Gingiva Squamous cell carcinoma 1 IV T4N0M0 Malignant
F11 91 M 45 Skin Squamous cell carcinoma (chronic inflammation of skin) of corona capitis – II T2N0M0 Malignant
F12 92 F 56 Soft palate Squamous cell carcinoma 2 II T2N0M0 Malignant
F13 93 F 63 Nose Squamous cell carcinoma 2 III T3N0M0 Malignant
F14 94 M 42 Nose Squamous cell carcinoma (granuloma) 2–3 I T1N0M0 Malignant
F15 95 M 43 Nose Squamous cell carcinoma 2–3 III T3N0M0 Malignant
F16 96 M 56 Nose Squamous cell carcinoma 3 II T2N0M0 Malignant
G1 97 M 53 Skin Squamous cell carcinoma of upper lip 1 I T1N0M0 Malignant
G2 98 M 63 Skin Squamous cell carcinoma of crissum 1 I T1N0M0 Malignant
G3 99 M 80 Skin Squamous cell carcinoma of right face 2 II T2N0M0 Malignant
G4 100 M 72 Skin Squamous cell carcinoma of buttock 1 I T1N0M0 Malignant
G5 101 M 60 Skin Squamous cell carcinoma of buttock 1 II T3N0M0 Malignant
G6 102 M 68 Skin Squamous cell carcinoma of left tempus 1 I T1N0M0 Malignant
G7 103 M 62 Skin Squamous cell carcinoma of occipitalia 1 II T2N0M0 Malignant
G8 104 F 82 Skin Squamous cell carcinoma of face 2 I T1N0M0 Malignant
G9 105 M 32 Skin Dermatofibrosarcoma protuberans of left chest wall – Ib T2aN0M0 Malignant
G10 106 M 15 Skin Dermatofibrosarcoma protuberans of right lumbar part – Ib T2aN0M0 Malignant
G11 107 M 58 Skin Dermatofibrosarcoma protuberans of left dorsum of foot – Ib T2aN0M0 Malignant
G12 108 F 58 Skin Dermatofibrosarcoma protuberans of chest wall – Ia T1aN0M0 Malignant
G13 109 M 72 Adipose Low-grade well-differentiated liposarcoma of right thigh – Ia T1N0M0 Malignant
G14 110 F 68 Skin Intermediate-grade myxoid liposarcoma of waist and back – IIa T1N0M0 Malignant
G15 111 F 34 Skin Intermediate-grade myxoid liposarcoma of left thigh – IIb T2N0M0 Malignant
G16 112 F 40 Skin Intermediate-grade myxoid liposarcoma of left thigh – IIb T2N0M0 Malignant
H1 113 M 62 Skin Malignant melanoma of left foot – II T4N0M0 Malignant
H2 114 M 74 Skin Malignant melanoma of left foot – II T4N0M0 Malignant
H3 115 F 66 Skin Malignant melanoma with necrosis of chest wall – II T4N0M0 Malignant
H4 116 M 61 Skin Malignant melanoma of left sole of foot – II T4N0M0 Malignant
H5 117 M 52 Skin Malignant melanoma of left crissum – II T3N0M0 Malignant
H6 118 F 47 Skin Malignant melanoma (fibrous tissue and blood vessel) of right upper arm – II T4N0M0 Malignant
H7 119 F 70 Rectum Malignant melanoma – – – Malignant
H8 120 F 67 Rectum Malignant melanoma – – – Malignant
H9 121 F 30 Breast Invasive ductal carcinoma 1 I T1cN0M0 Malignant
H10 122 F 54 Breast Invasive ductal carcinoma 2 I T1N0M0 Malignant
H11 123 F 50 Breast Invasive ductal carcinoma (breast tissue) – IIIa T2N1M0 Malignant
H12 124 F 71 Breast Invasive ductal carcinoma 2 IIIa T2N2M0 Malignant
H13 125 F 37 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
H14 126 F 63 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
H15 127 F 65 Breast Invasive ductal carcinoma 2 II T2N0M0 Malignant
H16 128 F 35 Breast Invasive ductal carcinoma (sparse) 2 I T1N0M0 Malignant
I1 129 F 38 Breast Invasive lobular carcinoma – IIa T2N0M0 Malignant
I2 130 F 35 Breast Invasive lobular carcinoma – I T1N0M0 Malignant
I3 131 F 59 Breast Invasive lobular carcinoma – IIIb T4N0M0 Malignant
I4 132 F 69 Breast Invasive lobular carcinoma – IIa T2N0M0 Malignant
I5 133 F 51 Breast Invasive lobular carcinoma – IIb T2N1M0 Malignant
I6 134 F 47 Breast Invasive lobular carcinoma – IIb T2N1M0 Malignant
I7 135 F 70 Breast Invasive lobular carcinoma – IIa T2N0M0 Malignant
I8 136 F 70 Breast Invasive lobular carcinoma – IIIa T2N2M0 Malignant
I9 137 F 41 Ovary Adenocarcinoma (ovary tissue) – Ia T1aN0M0 Malignant
I10 138 F 32 Ovary Mucinous adenocarcinoma 1 I T1N0M0 Malignant
I11 139 F 73 Ovary Serous adenocarcinoma 2 Ib T1bN0M0 Malignant
I12 140 F 57 Ovary Papillary serous adenocarcinoma 2 Ic T1cN0M0 Malignant
I13 141 F 66 Ovary Serous adenocarcinoma 2 IIIa T3aN0M0 Malignant
I14 142 F 57 Ovary Serous adenocarcinoma 3 Ic T1cN0M0 Malignant
I15 143 F 55 Ovary Serous adenocarcinoma 3 Ia T1aN0M0 Malignant
I16 144 F 56 Ovary Serous adenocarcinoma 3 II T2N0M0 Malignant
J1 145 F 25 Ovary Disgerminoma – Ic T1cN0M0 Malignant
J2 146 F 8 Ovary Disgerminoma – IIb T2bN0M0 Malignant
J3 147 F 36 Ovary Disgerminoma – Ib T1bN0M0 Malignant
J4 148 F 11 Ovary Disgerminoma – I T1N0M0 Malignant
J5 149 F 46 Ovary Moderately differentiated sertoli-stromal cell tumor – Ia T1aN0M0 Malignant
J6 150 F 40 Ovary Moderately differentiated sertoli-stromal cell tumor – I T1N0M0 Malignant
J7 151 F 59 Ovary Moderately differentiated sertoli-stromal cell tumor – I T1N0M0 Malignant
J8 152 F 26 Ovary Poorly differentiated sertoli-stromal cell tumor – I T1N0M0 Malignant
J9 153 F 40 Uterus Endometrioid adenocarcinoma 1 II T2N0M0 Malignant
J10 154 F 65 Uterus Endometrioid adenocarcinoma 1 Ia T1aN0M0 Malignant
J11 155 F 53 Uterus Endometrioid adenocarcinoma 1 Ib T1bN0M0 Malignant
J12 156 F 50 Uterus Endometrioid adenocarcinoma 2 IIb T2bN0M0 Malignant
J13 157 F 57 Uterus Endometrioid adenocarcinoma 2–3 Ic T1cN0M0 Malignant
J14 158 F 48 Uterus Adenocarcinoma 3 IIa T2N0M0 Malignant
J15 159 F 64 Uterus Adenocarcinoma 3 Ib T1bN0M0 Malignant
J16 160 F 57 Uterus Endometrioid adenocarcinoma 3 Ic T1cN0M0 Malignant
K1 161 F 62 Uterine cervix Squamous cell carcinoma 1 I T1N0M0 Malignant
K2 162 F 49 Uterine cervix Squamous cell carcinoma 1 I T1N0M0 Malignant
K3 163 F 55 Uterine cervix Squamous cell carcinoma 2 IIa T2aN0M0 Malignant
K4 164 F 41 Uterine cervix Squamous cell carcinoma 2 I T1N0M0 Malignant
K5 165 F 38 Uterine cervix Squamous cell carcinoma 2 Ib T1bN0M0 Malignant
K6 166 F 49 Uterine cervix Squamous cell carcinoma 3 I T1N0M0 Malignant
K7 167 F 37 Uterine cervix Squamous cell carcinoma 2 I T1N0M0 Malignant
K8 168 F 29 Uterine cervix Squamous cell carcinoma 3 I T1N0M0 Malignant
K9 169 M 70 Prostate Adenocarcinoma (gleason grade:4, score:3+4) 2 III T3N0M0 Malignant
K10 170 M 73 Prostate Adenocarcinoma (gleason grade:4, score:3+4) 1 II T2N0M0 Malignant
K11 171 M 73 Prostate Adenocarcinoma (sparse) – II T2N0M0 Malignant
K12 172 M 64 Prostate Adenocarcinoma (gleason grade:3, score:3+3) 2 II T2aN0M0 Malignant
K13 173 M 58 Prostate Adenocarcinoma (gleason grade:3, score:3+3) 2–3 II T2N0M0 Malignant
K14 174 M 62 Prostate Adenocarcinoma (gleason grade:3, score:3+4) 2–3 IV T3N1M1b Malignant
K15 175 M 82 Prostate Adenocarcinoma (gleason grade:5, score:4+5) 3 II T2N0M0 Malignant
K16 176 M 40 Prostate Adenocarcinoma (gleason grade:4, score:4+4) 3 IV T2N1M1b Malignant
L1 177 M 70 Testis Seminoma (sparse) – I T1N0M0 Malignant
L2 178 M 30 Testis Seminoma (sparse) – I T1N0M0 Malignant
L3 179 M 32 Testis Seminoma – I T1N0M0 Malignant
L4 180 M 35 Testis Seminoma – I T4N0M0 Malignant
L5 181 M 42 Testis Seminoma – I T2N0M0 Malignant
L6 182 M 38 Testis Seminoma – I T1N0M0 Malignant
L7 183 M 44 Testis Seminoma – I T1N0M0 Malignant
L8 184 M 34 Testis Seminoma – I T1N0M0 Malignant
L9 185 M 59 Kidney Clear cell carcinoma 1 I T1N0M0 Malignant
L10 186 M 70 Kidney Clear cell carcinoma 1 I T1N0M0 Malignant
L11 187 M 76 Kidney Clear cell carcinoma (sparse) – IV T4N0M0 Malignant
L12 188 F 57 Kidney Clear cell carcinoma 2 I T1N0M0 Malignant
L13 189 M 46 Kidney Clear cell carcinoma 1 I T1N0M0 Malignant
L14 190 M 54 Kidney Clear cell carcinoma 1 I T1N0M0 Malignant
L15 191 M 76 Kidney Clear cell carcinoma 2 I T1N0M0 Malignant
L16 192 M 40 Kidney Clear cell carcinoma 1 I T1N0M0 Malignant
M1 193 M 55 Kidney Granular cell tumor 2 II T2N0M0 Malignant
M2 194 M 71 Kidney Granular cell tumor 2 I T1N0M0 Malignant
M3 195 F 42 Kidney Granular cell tumor 2 II T2N0M0 Malignant
M4 196 M 41 Kidney Granular cell tumor 2 II T2N0M0 Malignant
M5 197 M 83 Kidney Granular cell tumor 3 II T2N0M0 Malignant
M6 198 M 49 Kidney Granular cell tumor 3 II T2N0M0 Malignant
M7 199 M 77 Kidney Granular cell tumor 2 I T1N0M0 Malignant
M8 200 M 63 Kidney Granular cell tumor 1 II T2N0M0 Malignant
M9 201 M 48 Bladder Transitional cell carcinoma 2 I T1N0M0 Malignant
M10 202 M 45 Bladder Transitional cell carcinoma 2 III T3biiN0M0 Malignant
M11 203 M 67 Bladder Transitional cell carcinoma 2 I T1N0M0 Malignant
M12 204 M 55 Bladder Transitional cell carcinoma 2 III T3biiN0M0 Malignant
M13 205 F 36 Bladder Transitional cell carcinoma 1–2 II T2N0M0 Malignant
M14 206 M 74 Bladder Transitional cell carcinoma 2 II T2N0M0 Malignant
M15 207 M 50 Bladder Transitional cell carcinoma 2 III T3biiN0M0 Malignant
M16 208 M 62 Bladder Transitional cell carcinoma 3 I T1N0M0 Malignant
N1 209 – – Skin Malignant melanoma (tissue marker) – – – Malignant

† For precise diagnosis, refer to pathology description.

**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.

TNM grading:

T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes

M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis

Find overlapping cases with this tissue array:
© 2003 - 2011 US Biomax Inc., custsrv@biomax.us, Tel: (800) 935-1357 | Privacy Policy

Authorize.Net Seal Starfield Seal